Skip to main content
Veterinary Medicines

AviPro THYMOVAC Lyophilisate for use in drinking water

Authorised
  • Chicken anaemia virus, strain CUX-1, Live

Product identification

Medicine name:
AviPro THYMOVAC Lyophilisate for use in drinking water
Avipro Thymovac Lyofilisaat voor gebruik in drinkwater
Avipro Thymovac Lyophilisat pour administration dans l'eau de boisson
Avipro Thymovac Lyophilisat zum Eingeben über das Trinkwasser
Active substance:
  • Chicken anaemia virus, strain CUX-1, Live
Target species:
  • Chicken
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Chicken anaemia virus, strain CUX-1, Live
    31622.00
    50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken
      • Meat and offal
        no withdrawal period
      • Egg
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD04
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • (ID10): 1 Box with 10 Bottle (Glass) with 10000 Dose (100000 Dose)
  • (ID9): 1 Box with 1 Bottle (Glass) with 10000 Dose (10000 Dose)
  • (ID8): 1 Box with 10 Bottle (Glass) with 5000 Dose (50000 Dose)
  • (ID7): 1 Box with 1 Bottle (Glass) with 5000 Dose (5000 Dose)
  • (ID6): 1 Box with 10 Bottle (Glass) with 2500 Dose (25000 Dose)
  • (ID5): 1 Box with 1 Bottle (Glass) with 2500 Dose (2500 Dose)
  • (ID1): 1 Box with 1 Bottle (Glass) with 500 Dose (500 Dose)
  • (ID2): 1 Box with 10 Bottle (Glass) with 500 Dose (5000 Dose)
  • (ID4): 1 Box with 10 Bottle (Glass) with 1000 Dose (10000 Dose)
  • (ID3): 1 Box with 1 Bottle (Glass) with 1000 Dose (1000 Dose)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lohmann Animal Health GmbH
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V345362
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0247/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 18/08/2025
French (PDF)
Published on: 18/08/2025
German (PDF)
Published on: 18/08/2025

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 18/08/2025
French (PDF)
Published on: 18/08/2025
German (PDF)
Published on: 18/08/2025

Combined File of all Documents

English (PDF)
Published on: 5/11/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 18/08/2025
French (PDF)
Published on: 18/08/2025
German (PDF)
Published on: 18/08/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."